{
    "organizations": [],
    "uuid": "3431b0dfefc762c9a2776766e5237ebd5f4d47c8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-henan-lingrui-pharmaceutical-to-ac/brief-henan-lingrui-pharmaceutical-to-acquire-33-33-pct-stake-in-biological-pharmaceutical-firm-for-66-7-mln-yuan-idUSL3N1RQ43D",
    "ord_in_thread": 0,
    "title": "BRIEF-Henan Lingrui Pharmaceutical to acquire 33.33 pct stake in biological pharmaceutical firm for 66.7 mln yuan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 13(Reuters) - Henan Lingrui Pharmaceutical Co Ltd\n* Says it plans to acquire 33.33 percent stake in a biological pharmaceutical firm for 66.7 million yuan\n* Says it will increase stake in the biological pharmaceutical firm to 90.5 percent\nSource text in Chinese: goo.gl/wLnV3P\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-04-13T17:26:00.000+03:00",
    "crawled": "2018-04-14T13:36:36.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "henan",
        "lingrui",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "plan",
        "acquire",
        "percent",
        "stake",
        "biological",
        "pharmaceutical",
        "firm",
        "million",
        "yuan",
        "say",
        "increase",
        "stake",
        "biological",
        "pharmaceutical",
        "firm",
        "percent",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}